Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism-Reference-Cited by-同舟云学术

Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism

Published:2005-08 Issue:33 Volume:280 Page:29728-29742
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Fu Maofu,Wang Chenguang,Rao Mahadev,Wu Xiaofang,Bouras Toula,Zhang Xueping,Li Zhiping,Jiao Xuanmao,Yang Jianguo,Li Anping,Perkins Neil D.,Thimmapaya Bayar,Kung Andrew L.,Munoz Alberto,Giordano Antonio,Lisanti Michael P.,Pestell Richard G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference88 articles.

1. CDK inhibitors: positive and negative regulators of G1-phase progression

2. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1

3. Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

4. Mouse Development and Cell Proliferation in the Absence of D-Cyclins

5. Mammary Glands of Aly Mice: Developmental Changes and Lactation-Related Expression of Specific Proteins, α-Casein, GlyCAM-1 and MAdCAM-1

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription;Oncogenesis;2024-01-08

2. Different Cyclins and Their Significance in Breast Cancer;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023

3. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-01

4. Less-well known functions of cyclin/CDK complexes;Seminars in Cell & Developmental Biology;2020-11

5. Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology;Expert Review of Anticancer Therapy;2019-06-20